Page last updated: 2024-10-30

ketotifen and Tachycardia

ketotifen has been researched along with Tachycardia in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Research Excerpts

ExcerptRelevanceReference
" These effects were well maintained after chronic dosing with no signs of beta1-adrenoceptor desensitization."2.69Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers. ( Brodde, OE; Daul, AE; Karl, I; Mennicke, K; Philipp, T; Schäfers, RF, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schäfers, RF1
Karl, I1
Mennicke, K1
Daul, AE1
Philipp, T1
Brodde, OE1

Trials

1 trial available for ketotifen and Tachycardia

ArticleYear
Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
    British journal of clinical pharmacology, 1999, Volume: 47, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Anti-Allergic Agents; Dose-Response Relationship, Drug; Double-Blin

1999